Pharmacological treatment of obesity for Primary Care physicians

Obesity is a disease of high prevalence in Primary Care clinics. It is associated with major comorbidities (dyslipidaemia, diabetes, hypertension) that increase morbidity and mortality, health expenditure, and reduces the quality of life of patients. Changes in lifestyle are still the pillars of the...

Full description

Saved in:
Bibliographic Details
Published inSemergen, medicina de familia Vol. 45; no. 8; p. 559
Main Authors Rubio Herrera, M A, Fernández-García, J M, Corio Andújar, R, Santos Altozano, C, Urieta Carpi, J J
Format Journal Article
LanguageSpanish
Published Spain 01.11.2019
Subjects
Anti-Obesity Agents - therapeutic use
Decision Trees
Humans
Obesity - drug therapy
Primary Health Care
Obesidad
Obesity
Liraglutida
Orlistat
Sobrepeso
Bupropion/naltrexone
Bupropión/naltrexona
Liraglutide
Overweight
Online AccessGet full text

Cover

More Information
Summary:Obesity is a disease of high prevalence in Primary Care clinics. It is associated with major comorbidities (dyslipidaemia, diabetes, hypertension) that increase morbidity and mortality, health expenditure, and reduces the quality of life of patients. Changes in lifestyle are still the pillars of the treatment of excess weight. Pharmacological treatment should be considered when there are difficulties in achieving weight loss goals. In this article, a review is presented on the currently authorised drugs for the treatment of obesity and overweight with major comorbidities.
ISSN:1578-8865
DOI:10.1016/j.semerg.2019.04.005